GRAIL reported a 28% increase in total revenue to $40.8 million for Q1 2026, driven by a 37% rise in Galleri test revenue and a 50% increase in test volume to over 56,000. The company plans to integrate its Galleri cancer detection test into Epic's electronic health record platform to expand nationwide access by the end of 2026. Despite a net loss of $93.2 million, GRAIL improved its financial performance compared to last year and will present new clinical data at the 2026 ASCO Annual Meeting. This integration and ongoing clinical validation aim to boost adoption and early cancer detection capabilities.
Traini, a Silicon Valley AI company specializing in pet emotional intelligence, has partnered with TECNO to integrate its pet emotion translation technology natively into TECNO smartphones. This allows users to understand their pets' emotions and nee...
Law Offices of Howard G. Smith announced class action lawsuits against Futu Holdings, Hub Group, Insulet Corporation, and Photronics for allegedly making false or misleading statements during specific periods. The lawsuits claim these companies misre...
Ahead of its August 18, 2026 earnings report, Home Depot has seen mixed investor activity. A public official sold between $15,001 and $50,000 worth of stock, while Copeland Capital Management drastically reduced its stake by 94.6%. Conversely, Adviso...
Danaher Corporation reported stronger-than-expected Q2 2026 earnings and revenue, driven by its Life Sciences segment, with EPS of $1.94 and revenue of $6.27 billion beating estimates. However, the stock fell nearly 12% in premarket trading due to in...
Hancock Whitney Corporation is set to report its Q2 earnings on July 21, 2026, with analysts expecting an EPS of $1.55 and revenue near $399 million. The bank recently gained regulatory approval to acquire One Florida Bank, a strategic move expected ...
